Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Germaine Laboratories is a privately held U.S. diagnostics company that develops, manufactures, and supplies in vitro diagnostic tests, analyzers, reagents, and related medical testing supplies. The company focuses on professional-use, point-of-care, and over-the-counter products across medical, drug testing, veterinary, and food and beverage applications. Its branded portfolio includes products such as AccuHome, Aim, AimScreen, AimStep, AimStrip, AimTab, Compliance Gold, SafeCup, and StrepAim, spanning pregnancy, urinalysis, infectious disease, hematology, glucose, and drugs-of-abuse testing. Germaine Laboratories operates an FDA-registered manufacturing facility, states that it manufactures under cGMP, and reports ISO 13485:2016 certification for relevant IVD manufacturing and distribution activities. The business appears to be primarily a commercial diagnostics supplier and OEM/private-label manufacturing partner rather than a therapeutic biotech drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Germaine Laboratories.